EVALUATION OF IMMUNOGENICITY OF THE RECOMBINANT INHIBITOR OF APOPTOSIS PROTEIN OF SCHISTOSOMAJAPONICUM IN MOUSE MODEL

Chao HU,Rong LUO,Jin-wei DAO,Yu-qing WANG,Jiang-ping ZHAO,Ke LU,Hao LI,Jin-ming LIU,Guo-feng CHENG
2014-01-01
Abstract:To evaluate the protective immunity induced by the inhibitor of apoptosis protein of Schistosoma japonicum (rSjIAP) in BALB/c mice, SjIAP gene was amplified in PCR and subcloned into the plasmid pET-28a(+) to construct a recombinant expression plasmid pET-28a(+)-SjIAP. The recombinant protein SjIAP was expressed in E.coli. The purified recombinant protein was used to immunize New Zealand rabbit to produce polyclonal antibodies. BALB/c mice were immunized with the purified recombinant SjIAP emulsified in Freund's adjuvant. The levels of specific anti-rSjIAP antibodies in serum samples of immunized animals and cytokines in culture supernatants of the spleen lymphocytes in response to the T cell mitogen rSjIAP were detected in ELISA. Then all mice were challenged with Schistosoma japonicum cercariae and terminated at thirty-eight days later. The rates of worm reduction and liver egg reduction were counted. Western blot analysis indicated that rSjIAP reacted with rabbit polyclonal antibodies. High levels of specific IgG and IgG subclass (IgG1, IgG2a, IgG2b and IgG4) antibodies as well as IFN-γ, IL-2 and IL-4 were detected in animal serum samples. The immunized mice showed worm reduction by 31.5%and liver egg reduction by 37.2%. The present study indicated that immunization of rSjIAP induced partial protection against schistosomiasis in BALB/c mice, suggesting that SjIAP might be a potential candidate for vaccine development.
What problem does this paper attempt to address?